Dr Ching Chi Keong
Director of Cardiac Electrophysiology and Pacing, NHCS, Singapore
Dr Lars Wallentin
Prof of Cardiology, Uppsala University Hospital, Sweden

Novel Biomarker-based Risk Score in AF: ABC Risk Score


  • ABC risk scores have been well validated and calibrated with a good discriminative ability for risk stratification of stroke and bleeding in non-valvular AF patients
  • The ABC risk score offers a better risk prediction for death than clinical variables
  • ABC risk scores provides a new tool to tailor the intensity, duration and type of treatment for the patient with non-valvular AF

Atrial Fibrillation is associated with a 5-fold increased risk of stroke and thus stroke prevention is the fundamental part of management of Atrial Fibrillation (AF) patients. The choice of antithrombotic therapy for AF patients need to balance the risk of stroke against major bleeding.

Compared with non-Asians, the incidence of AF-related risks of stroke and bleeding in Asians is generally higher. By attending this webinar, you will have better knowledge and competence on: 

  1. The current situation and challenges of stroke prevention in Atrial Fibrillation in Asia Pacific region
  2. The introduction of GDF-15 the strongest bleeding marker 
  3. The clinical utility and validation data of the novel ABC (Age, Biomarker, Clinical History) risk scores in stroke prevention as well as it’s performance

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy. [...]


CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021
Dr James L Januzzi